Silencing of AR-v19 in bladder cancer lines resulted in a decrease in cell viability and increases in apoptosis and the expression of related molecules, such as cleaved poly(ADP-ribose) polymerase (PARP) [77]. This evidence concerns the gene AR and urinary bladder cancer.